News: NOX Noxopharm Says Lupin Trial Is To Be Expanded To Include An Additional Dose Cohort Where...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 23 (Reuters) - Noxopharm Ltd (NOX) :

    • NOXOPHARM SAYS LUPIN TRIAL IS TO BE EXPANDED TO INCLUDE AN ADDITIONAL DOSE COHORT WHERE THE ADDITIONAL PATIENTS ARE TO BE TREATED WITH VEYONDA 1200 MG
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.4¢
Change
-0.001(1.05%)
Mkt cap ! $27.47M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $204 2.171K

Buyers (Bids)

No. Vol. Price($)
1 4106 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 7855 1
View Market Depth
Last trade - 10.04am 16/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.